# Alfentanil

## Alfentanil inj 1mg/2mL

#### 一般可用

| 藥品代碼       | IALF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:---------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Analgesia & anaesthetic induction in both short & long surgical procedures.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 用法用量       | Individualised dosage. ■Administration of analgesic; Adjunct - Surgical procedure: surgery duration 30 min or less; 8-20 mcg/kg IV， then continuous IV infusion of 0.5-1 mcg/kg/min; total dose 8-40 mcg/kg ■Administration of analgesic; Adjunct - Surgical procedure: surgery duration 30-60 min; 20-50 mcg/kg IV， then maintenance IV injections of 5-15 mcg/kg every 5-20 min; total dose up to 75 mcg/kg ■Administration of analgesic; Adjunct - Surgical procedure: surgery duration longer than 45 min; 50-75 mcg/kg IV， then continuous IV infusion of 0.5-3 mcg/kg/min ■Anesthesia: individualized according to type and duration of surgical procedure/anesthesia ■Anesthesia: when used as primary anesthetic agent; 130-245 mcg/kg induction dose followed by continuous IV infusion of 0.5-1.5 mcg/kg/min |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 禁忌           | Resp insufficiency. Special Precautions: CV disorders; impaired liver function.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 副作用         | Resp depression， apnoea， muscular rigidity， bradycardia， hypotension， dizziness， nausea， CNS disturbances.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 孕期用藥建議   | Human data suggest risk in 3 rd trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 哺乳期用藥建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

## Rapifen inj 1mg/2mL

#### 一般可用

| 藥品代碼       | IRAP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:---------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | an analgesic supplement and an anaesthetic induction agent.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 用法用量       | Use as an Induction Agent: An intravenous bolus dose of > or =120 micrograms/kg (17mL/70kg) RAPIFEN will induce hypnosis and analgesia while maintaining good cardiovascular stability in patients with adequate muscle relaxation. For short procedures， an initial dose 7-15 micrograms/kg at induction， with intermittent boluses up to 15 micrograms/kg (7-15 micrograms/kg) at 10-15 minute intervals are most useful. If the dose is less than 7micrograms/kg and IV injection slowly， most patients can still maintain normal respiratory function. the recommended additional dose is 3.5micrograms/kg. For procedures of longer duration， a higher dose may be given at induction and further increments titrated to effect. Duration of the procedure(min):10-30; Rapifen IV bolus dose: 20-40 Micrograms/kg ; 3-6mL/70kg; Duration of the procedure(min):30-60; Rapifen IV bolus dose: 40-80 Micrograms/kg ; 6-12mL/70kg; Duration of the procedure(min):>60; Rapifen IV bolus dose: 80-150 Micrograms/kg ; 12-20mL/70kg; When surgery is more prolonged or more traumatic， analgesia should be maintained by: ‧ either increments of up to 15 micrograms/kg (2mL/70kg) RAPIFEN when required (to avoid post-operative respiratory depression， no RAPIFEN should be administered during the last 10 minutes of surgery); ‧ or a RAPIFEN infusion at a rate of 0.5 to 1 microgram/kg/min (0.14mL/70kg/min) until 5 to 10 minutes before the completion of surgery. Continuous infusion is preferable for cases greater than 60 minutes duration. Rapifen should not be given in the last 10 minutes prior to completion of surgery. |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 禁忌           | Hypersensitivity to alfentanil or any component of the formulation. known intolerance to alfentanil.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 副作用         | Common Cardiovascular: Hypertension (18% )， Tachycardia (12% ) Gastrointestinal: Nausea (28% )， Vomiting (18% ) Musculoskeletal: Involuntary movement， Skeletal muscle (3% to 9% ) Serious Cardiovascular: Asystole， Bradyarrhythmia， Cardiac dysrhythmia， Hypotension (10% ) Immunologic: Anaphylaxis (Less than 1% ) Musculoskeletal: Muscle rigidity (17% ) Neurologic: Raised intracranial pressure， Seizure Respiratory: Apnea (3% to 9% )， Laryngeal spasm (0.3% to 1% )， Respiratory depression (1% to 3% ) Other: Serotonin syndrome                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 孕期用藥建議   | Human data suggest risk in 3 rd trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 哺乳期用藥建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

